top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.

Biblioteca

MARC Lista (tabellare)
Coltivirus Infections
Coltivirus Infections
Autore Gideon Informatics Inc
Edizione [1st ed.]
Pubbl/distr/stampa Los Angeles : , : Gideon Informatics, Incorporated, , 2021
Descrizione fisica 1 online resource (17 pages)
Disciplina 616.968
Altri autori (Persone) BergerStephen
Soggetto topico Tick-borne diseases
ISBN 1-4988-3241-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Intro -- Copyright -- Introduction: The GIDEON e-book series -- Table of Contents -- Colorado tick fever -- Epidemiology -- Agent -- Reservoir -- Vector -- Vehicle -- Incubation Period -- Diagnostic Tests -- Typical Adult Therapy -- Typical Pediatric Therapy -- Clinical Hints -- Synonyms -- References -- Clinical -- References -- Distribution Map -- Images -- Global status -- References -- Canada -- References -- The United States -- References -- Coltiviruses - Old World -- Epidemiology -- Agent -- Reservoir -- Vector -- Vehicle -- Incubation Period -- Diagnostic Tests -- Typical Adult Therapy -- Typical Pediatric Therapy -- Clinical Hints -- Synonyms -- References -- Clinical -- References -- Distribution Map -- Images -- Global status -- References -- China -- References -- The Czech Republic -- References -- France -- References -- Germany -- References -- Hungary -- References -- Indonesia -- References -- Vietnam -- References -- About GIDEON.
Altri titoli varianti Coltivirus Infections
Record Nr. UNINA-9910794402403321
Gideon Informatics Inc  
Los Angeles : , : Gideon Informatics, Incorporated, , 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Coltivirus Infections
Coltivirus Infections
Autore Gideon Informatics Inc
Edizione [1st ed.]
Pubbl/distr/stampa Los Angeles : , : Gideon Informatics, Incorporated, , 2021
Descrizione fisica 1 online resource (17 pages)
Disciplina 616.968
Altri autori (Persone) BergerStephen
Soggetto topico Tick-borne diseases
ISBN 1-4988-3241-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Intro -- Copyright -- Introduction: The GIDEON e-book series -- Table of Contents -- Colorado tick fever -- Epidemiology -- Agent -- Reservoir -- Vector -- Vehicle -- Incubation Period -- Diagnostic Tests -- Typical Adult Therapy -- Typical Pediatric Therapy -- Clinical Hints -- Synonyms -- References -- Clinical -- References -- Distribution Map -- Images -- Global status -- References -- Canada -- References -- The United States -- References -- Coltiviruses - Old World -- Epidemiology -- Agent -- Reservoir -- Vector -- Vehicle -- Incubation Period -- Diagnostic Tests -- Typical Adult Therapy -- Typical Pediatric Therapy -- Clinical Hints -- Synonyms -- References -- Clinical -- References -- Distribution Map -- Images -- Global status -- References -- China -- References -- The Czech Republic -- References -- France -- References -- Germany -- References -- Hungary -- References -- Indonesia -- References -- Vietnam -- References -- About GIDEON.
Altri titoli varianti Coltivirus Infections
Record Nr. UNINA-9910819691303321
Gideon Informatics Inc  
Los Angeles : , : Gideon Informatics, Incorporated, , 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
COVID-19
COVID-19
Autore Gideon Informatics Inc
Edizione [1st ed.]
Pubbl/distr/stampa Los Angeles : , : Gideon Informatics, Incorporated, , 2022
Descrizione fisica 1 online resource (966 pages)
Altri autori (Persone) BergerStephen
Soggetto topico SARS (Disease)
ISBN 1-4988-3413-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Intro -- Copyright -- Introduction: The GIDEON e-book series -- Table of Contents -- COVID-19 -- Epidemiology -- Agent -- Reservoir -- Vector -- Vehicle -- Incubation Period -- Diagnostic Tests -- Typical Adult Therapy -- Typical Pediatric Therapy -- Vaccines -- Clinical Hints -- Synonyms -- References -- Clinical -- References -- Distribution Map -- Images -- Global status -- References -- Afghanistan -- References -- Albania -- References -- Algeria -- References -- American Samoa -- References -- Andorra -- References -- Angola -- References -- Anguilla -- References -- Antigua and Barbuda -- References -- The Antilles (miscellaneous) -- References -- Argentina -- References -- Armenia -- References -- Aruba -- References -- Australia -- References -- Austria -- References -- Azerbaijan -- References -- The Azores -- References -- The Bahamas -- References -- Bahrain -- References -- Bangladesh -- References -- Barbados -- References -- Belarus -- References -- Belgium -- References -- Belize -- References -- Benin -- References -- Bermuda -- References -- Bhutan -- References -- Bolivia -- References -- Bosnia and Herzegovina -- References -- Botswana -- References -- Brazil -- References -- The British Virgin Islands -- References -- Brunei -- References -- Bulgaria -- References -- Burkina Faso -- References -- Burundi -- References -- Cambodia -- References -- Cameroon -- References -- Canada -- References -- The Canary Islands -- References -- Cape Verde -- References -- The Cayman Islands -- References -- Central African Republic -- References -- Chad -- References -- Chile -- References -- China -- References -- Colombia -- References -- The Comoros and Mayotte -- References -- Congo -- References -- The Cook Islands -- References -- Costa Rica -- References -- Croatia -- References -- Cuba -- References -- Cyprus -- References.
The Czech Republic -- References -- The Democratic Republic of Congo -- References -- Denmark -- References -- Djibouti -- References -- Dominica -- References -- The Dominican Republic -- References -- East Timor -- References -- Ecuador -- References -- Egypt -- References -- El Salvador -- References -- Equatorial Guinea -- References -- Eritrea -- References -- Estonia -- References -- Eswatini -- References -- Ethiopia -- References -- The Falkland Islands -- References -- Fiji -- References -- Finland -- References -- France -- References -- French Guiana -- References -- French Polynesia -- References -- Gabon -- References -- Gambia -- References -- Georgia -- References -- Germany -- References -- Ghana -- References -- Gibraltar -- References -- Greece -- References -- Greenland -- References -- Grenada -- References -- Guadeloupe -- References -- Guam -- References -- Guatemala -- References -- Guinea -- References -- Guinea Bissau -- References -- Guyana -- References -- Haiti -- References -- Honduras -- References -- Hong Kong -- References -- Hungary -- References -- Iceland -- References -- India -- References -- Indonesia -- References -- Iran -- References -- Iraq -- References -- Ireland -- References -- Israel -- References -- Italy -- References -- Ivory Coast -- References -- Jamaica -- References -- Japan -- References -- Jordan -- References -- Kazakhstan -- References -- Kenya -- References -- Kiribati -- References -- Kosovo -- References -- Kuwait -- References -- Kyrgyzstan -- References -- Laos -- References -- Latvia -- References -- Lebanon -- References -- Lesotho -- References -- Liberia -- References -- Libya -- References -- Liechtenstein -- References -- Lithuania -- References -- Luxembourg -- References -- Macao -- References -- Madagascar -- References -- Malawi -- References -- Malaysia -- References.
The Maldives -- References -- Mali -- References -- Malta -- References -- The Marshall Islands -- References -- Martinique -- References -- Mauritania -- References -- Mauritius -- References -- Mexico -- References -- Micronesia -- References -- Moldova -- References -- Monaco -- References -- Mongolia -- References -- Montenegro -- References -- Montserrat -- References -- Morocco -- References -- Mozambique -- References -- Myanmar -- References -- Namibia -- References -- Nauru -- Nepal -- References -- The Netherlands -- References -- New Caledonia -- References -- New Zealand -- References -- Nicaragua -- References -- Niger -- References -- Nigeria -- References -- Niue -- References -- North Macedonia -- References -- Northern Ireland -- References -- The Northern Marianas -- References -- Norway -- References -- Oman -- References -- Pakistan -- References -- Palau -- References -- Panama -- References -- Papua New Guinea -- References -- Paraguay -- References -- North Korea -- References -- Peru -- References -- The Philippines -- References -- Pitcairn Island -- Poland -- References -- Portugal -- References -- Puerto Rico -- References -- Qatar -- References -- South Korea -- References -- Reunion -- References -- Romania -- References -- The Russian Federation -- References -- Rwanda -- References -- Samoa -- References -- San Marino -- References -- Sao Tome and Principe -- References -- Saudi Arabia -- References -- Scotland -- References -- Senegal -- References -- Serbia -- References -- The Seychelles -- References -- Sierra Leone -- References -- Singapore -- References -- Slovakia -- References -- Slovenia -- References -- The Solomon Islands -- References -- Somalia -- References -- South Africa -- References -- South Sudan -- References -- Spain -- References -- Sri Lanka -- References -- St. Helena -- References.
Saint Kitts and Nevis -- References -- Saint Lucia -- References -- Saint Vincent and The Grenadines -- References -- Sudan -- References -- Suriname -- References -- Sweden -- References -- Switzerland -- References -- Syria -- References -- Taiwan -- References -- Tajikistan -- References -- Tanzania -- References -- Thailand -- References -- Togo -- References -- Tokelau -- Tonga -- References -- Trinidad and Tobago -- References -- Tunisia -- References -- Turkey -- References -- Turkmenistan -- References -- The Turks and Caicos Islands -- References -- Tuvalu -- Uganda -- References -- Ukraine -- References -- The United Arab Emirates -- References -- The United Kingdom -- References -- The United States -- References -- Uruguay -- References -- Uzbekistan -- References -- Vanuatu -- References -- Venezuela -- References -- Vietnam -- References -- The U.S. Virgin Islands -- References -- Wallis and Futuna Islands -- References -- Western Sahara -- References -- Yemen -- References -- Zambia -- References -- Zimbabwe -- References -- Vaccines & -- Immunoglobulins -- Bamlanivimab -- Mechanism of Action -- Typical Adult Dosage -- Typical Pediatric Dosage -- Subsequent booster -- Toxic Effects for Bamlanivimab (2 listed) -- Contraindications for Bamlanivimab (0 listed) -- Trade names of Bamlanivimab (3 listed) -- Bebtelovimab -- Mechanism of Action -- Typical Adult Dosage -- Typical Pediatric Dosage -- Subsequent booster -- Toxic Effects for Bebtelovimab (5 listed) -- Contraindications for Bebtelovimab (0 listed) -- Trade names of Bebtelovimab (1 listed) -- Casirivimab / Imdevimab -- Mechanism of Action -- Typical Adult Dosage -- Typical Pediatric Dosage -- Subsequent booster -- Toxic Effects for Casirivimab / Imdevimab (6 listed) -- Contraindications for Casirivimab / Imdevimab (1 listed) -- Trade names of Casirivimab / Imdevimab (2 listed).
COVID-19 - inactivated vaccine -- Mechanism of Action -- Typical Adult Dosage -- Typical Pediatric Dosage -- Subsequent booster -- Toxic Effects for COVID-19 - inactivated vaccine (13 listed) -- Contraindications for COVID-19 - inactivated vaccine (2 listed) -- Trade names of COVID-19 - inactivated vaccine (9 listed) -- COVID-19 - mRNA vaccine -- Mechanism of Action -- Typical Adult Dosage -- Typical Pediatric Dosage -- Subsequent booster -- Toxic Effects for COVID-19 - mRNA vaccine (16 listed) -- Contraindications for COVID-19 - mRNA vaccine (2 listed) -- Trade names of COVID-19 - mRNA vaccine (8 listed) -- COVID-19 - recombinant nanoparticle vaccine -- Mechanism of Action -- Typical Adult Dosage -- Typical Pediatric Dosage -- Subsequent booster -- Toxic Effects for COVID-19 - recombinant nanoparticle vaccine (7 listed) -- Contraindications for COVID-19 - recombinant nanoparticle vaccine (3 listed) -- Trade names of COVID-19 - recombinant nanoparticle vaccine (10 listed) -- COVID-19 - viral vector vaccine -- Mechanism of Action -- Typical Adult Dosage -- Typical Pediatric Dosage -- Subsequent booster -- Toxic Effects for COVID-19 - viral vector vaccine (11 listed) -- Contraindications for COVID-19 - viral vector vaccine (2 listed) -- Trade names of COVID-19 - viral vector vaccine (14 listed) -- Regdanvimab -- Mechanism of Action -- Typical Adult Dosage -- Typical Pediatric Dosage -- Subsequent booster -- Toxic Effects for Regdanvimab (2 listed) -- Contraindications for Regdanvimab (0 listed) -- Trade names of Regdanvimab (2 listed) -- Sotrovimab -- Mechanism of Action -- Typical Adult Dosage -- Typical Pediatric Dosage -- Subsequent booster -- Toxic Effects for Sotrovimab (3 listed) -- Contraindications for Sotrovimab (1 listed) -- Trade names of Sotrovimab (0 listed) -- Tixagevimab / Cilgavimab -- Mechanism of Action -- Typical Adult Dosage.
Typical Pediatric Dosage.
Record Nr. UNINA-9910795636603321
Gideon Informatics Inc  
Los Angeles : , : Gideon Informatics, Incorporated, , 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
COVID-19
COVID-19
Autore Gideon Informatics Inc
Edizione [1st ed.]
Pubbl/distr/stampa Los Angeles : , : Gideon Informatics, Incorporated, , 2022
Descrizione fisica 1 online resource (966 pages)
Altri autori (Persone) BergerStephen
Soggetto topico SARS (Disease)
ISBN 1-4988-3413-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Intro -- Copyright -- Introduction: The GIDEON e-book series -- Table of Contents -- COVID-19 -- Epidemiology -- Agent -- Reservoir -- Vector -- Vehicle -- Incubation Period -- Diagnostic Tests -- Typical Adult Therapy -- Typical Pediatric Therapy -- Vaccines -- Clinical Hints -- Synonyms -- References -- Clinical -- References -- Distribution Map -- Images -- Global status -- References -- Afghanistan -- References -- Albania -- References -- Algeria -- References -- American Samoa -- References -- Andorra -- References -- Angola -- References -- Anguilla -- References -- Antigua and Barbuda -- References -- The Antilles (miscellaneous) -- References -- Argentina -- References -- Armenia -- References -- Aruba -- References -- Australia -- References -- Austria -- References -- Azerbaijan -- References -- The Azores -- References -- The Bahamas -- References -- Bahrain -- References -- Bangladesh -- References -- Barbados -- References -- Belarus -- References -- Belgium -- References -- Belize -- References -- Benin -- References -- Bermuda -- References -- Bhutan -- References -- Bolivia -- References -- Bosnia and Herzegovina -- References -- Botswana -- References -- Brazil -- References -- The British Virgin Islands -- References -- Brunei -- References -- Bulgaria -- References -- Burkina Faso -- References -- Burundi -- References -- Cambodia -- References -- Cameroon -- References -- Canada -- References -- The Canary Islands -- References -- Cape Verde -- References -- The Cayman Islands -- References -- Central African Republic -- References -- Chad -- References -- Chile -- References -- China -- References -- Colombia -- References -- The Comoros and Mayotte -- References -- Congo -- References -- The Cook Islands -- References -- Costa Rica -- References -- Croatia -- References -- Cuba -- References -- Cyprus -- References.
The Czech Republic -- References -- The Democratic Republic of Congo -- References -- Denmark -- References -- Djibouti -- References -- Dominica -- References -- The Dominican Republic -- References -- East Timor -- References -- Ecuador -- References -- Egypt -- References -- El Salvador -- References -- Equatorial Guinea -- References -- Eritrea -- References -- Estonia -- References -- Eswatini -- References -- Ethiopia -- References -- The Falkland Islands -- References -- Fiji -- References -- Finland -- References -- France -- References -- French Guiana -- References -- French Polynesia -- References -- Gabon -- References -- Gambia -- References -- Georgia -- References -- Germany -- References -- Ghana -- References -- Gibraltar -- References -- Greece -- References -- Greenland -- References -- Grenada -- References -- Guadeloupe -- References -- Guam -- References -- Guatemala -- References -- Guinea -- References -- Guinea Bissau -- References -- Guyana -- References -- Haiti -- References -- Honduras -- References -- Hong Kong -- References -- Hungary -- References -- Iceland -- References -- India -- References -- Indonesia -- References -- Iran -- References -- Iraq -- References -- Ireland -- References -- Israel -- References -- Italy -- References -- Ivory Coast -- References -- Jamaica -- References -- Japan -- References -- Jordan -- References -- Kazakhstan -- References -- Kenya -- References -- Kiribati -- References -- Kosovo -- References -- Kuwait -- References -- Kyrgyzstan -- References -- Laos -- References -- Latvia -- References -- Lebanon -- References -- Lesotho -- References -- Liberia -- References -- Libya -- References -- Liechtenstein -- References -- Lithuania -- References -- Luxembourg -- References -- Macao -- References -- Madagascar -- References -- Malawi -- References -- Malaysia -- References.
The Maldives -- References -- Mali -- References -- Malta -- References -- The Marshall Islands -- References -- Martinique -- References -- Mauritania -- References -- Mauritius -- References -- Mexico -- References -- Micronesia -- References -- Moldova -- References -- Monaco -- References -- Mongolia -- References -- Montenegro -- References -- Montserrat -- References -- Morocco -- References -- Mozambique -- References -- Myanmar -- References -- Namibia -- References -- Nauru -- Nepal -- References -- The Netherlands -- References -- New Caledonia -- References -- New Zealand -- References -- Nicaragua -- References -- Niger -- References -- Nigeria -- References -- Niue -- References -- North Macedonia -- References -- Northern Ireland -- References -- The Northern Marianas -- References -- Norway -- References -- Oman -- References -- Pakistan -- References -- Palau -- References -- Panama -- References -- Papua New Guinea -- References -- Paraguay -- References -- North Korea -- References -- Peru -- References -- The Philippines -- References -- Pitcairn Island -- Poland -- References -- Portugal -- References -- Puerto Rico -- References -- Qatar -- References -- South Korea -- References -- Reunion -- References -- Romania -- References -- The Russian Federation -- References -- Rwanda -- References -- Samoa -- References -- San Marino -- References -- Sao Tome and Principe -- References -- Saudi Arabia -- References -- Scotland -- References -- Senegal -- References -- Serbia -- References -- The Seychelles -- References -- Sierra Leone -- References -- Singapore -- References -- Slovakia -- References -- Slovenia -- References -- The Solomon Islands -- References -- Somalia -- References -- South Africa -- References -- South Sudan -- References -- Spain -- References -- Sri Lanka -- References -- St. Helena -- References.
Saint Kitts and Nevis -- References -- Saint Lucia -- References -- Saint Vincent and The Grenadines -- References -- Sudan -- References -- Suriname -- References -- Sweden -- References -- Switzerland -- References -- Syria -- References -- Taiwan -- References -- Tajikistan -- References -- Tanzania -- References -- Thailand -- References -- Togo -- References -- Tokelau -- Tonga -- References -- Trinidad and Tobago -- References -- Tunisia -- References -- Turkey -- References -- Turkmenistan -- References -- The Turks and Caicos Islands -- References -- Tuvalu -- Uganda -- References -- Ukraine -- References -- The United Arab Emirates -- References -- The United Kingdom -- References -- The United States -- References -- Uruguay -- References -- Uzbekistan -- References -- Vanuatu -- References -- Venezuela -- References -- Vietnam -- References -- The U.S. Virgin Islands -- References -- Wallis and Futuna Islands -- References -- Western Sahara -- References -- Yemen -- References -- Zambia -- References -- Zimbabwe -- References -- Vaccines & -- Immunoglobulins -- Bamlanivimab -- Mechanism of Action -- Typical Adult Dosage -- Typical Pediatric Dosage -- Subsequent booster -- Toxic Effects for Bamlanivimab (2 listed) -- Contraindications for Bamlanivimab (0 listed) -- Trade names of Bamlanivimab (3 listed) -- Bebtelovimab -- Mechanism of Action -- Typical Adult Dosage -- Typical Pediatric Dosage -- Subsequent booster -- Toxic Effects for Bebtelovimab (5 listed) -- Contraindications for Bebtelovimab (0 listed) -- Trade names of Bebtelovimab (1 listed) -- Casirivimab / Imdevimab -- Mechanism of Action -- Typical Adult Dosage -- Typical Pediatric Dosage -- Subsequent booster -- Toxic Effects for Casirivimab / Imdevimab (6 listed) -- Contraindications for Casirivimab / Imdevimab (1 listed) -- Trade names of Casirivimab / Imdevimab (2 listed).
COVID-19 - inactivated vaccine -- Mechanism of Action -- Typical Adult Dosage -- Typical Pediatric Dosage -- Subsequent booster -- Toxic Effects for COVID-19 - inactivated vaccine (13 listed) -- Contraindications for COVID-19 - inactivated vaccine (2 listed) -- Trade names of COVID-19 - inactivated vaccine (9 listed) -- COVID-19 - mRNA vaccine -- Mechanism of Action -- Typical Adult Dosage -- Typical Pediatric Dosage -- Subsequent booster -- Toxic Effects for COVID-19 - mRNA vaccine (16 listed) -- Contraindications for COVID-19 - mRNA vaccine (2 listed) -- Trade names of COVID-19 - mRNA vaccine (8 listed) -- COVID-19 - recombinant nanoparticle vaccine -- Mechanism of Action -- Typical Adult Dosage -- Typical Pediatric Dosage -- Subsequent booster -- Toxic Effects for COVID-19 - recombinant nanoparticle vaccine (7 listed) -- Contraindications for COVID-19 - recombinant nanoparticle vaccine (3 listed) -- Trade names of COVID-19 - recombinant nanoparticle vaccine (10 listed) -- COVID-19 - viral vector vaccine -- Mechanism of Action -- Typical Adult Dosage -- Typical Pediatric Dosage -- Subsequent booster -- Toxic Effects for COVID-19 - viral vector vaccine (11 listed) -- Contraindications for COVID-19 - viral vector vaccine (2 listed) -- Trade names of COVID-19 - viral vector vaccine (14 listed) -- Regdanvimab -- Mechanism of Action -- Typical Adult Dosage -- Typical Pediatric Dosage -- Subsequent booster -- Toxic Effects for Regdanvimab (2 listed) -- Contraindications for Regdanvimab (0 listed) -- Trade names of Regdanvimab (2 listed) -- Sotrovimab -- Mechanism of Action -- Typical Adult Dosage -- Typical Pediatric Dosage -- Subsequent booster -- Toxic Effects for Sotrovimab (3 listed) -- Contraindications for Sotrovimab (1 listed) -- Trade names of Sotrovimab (0 listed) -- Tixagevimab / Cilgavimab -- Mechanism of Action -- Typical Adult Dosage.
Typical Pediatric Dosage.
Record Nr. UNINA-9910826614603321
Gideon Informatics Inc  
Los Angeles : , : Gideon Informatics, Incorporated, , 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cutaneous Larva Migrans
Cutaneous Larva Migrans
Autore Gideon Informatics Inc
Pubbl/distr/stampa Los Angeles : , : Gideon Informatics, Incorporated, , 2021
Descrizione fisica 1 online resource (27 pages)
Disciplina 616.5
Altri autori (Persone) BergerStephen
Soggetto topico Skin - Infections
ISBN 1-4988-3247-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto CUTANEOUS LARVA MIGRANS: GLOBAL STATUS -- Copyright -- Introduction: The GIDEON e-book series -- Table of Contents -- Cutaneous larva migrans -- Epidemiology -- Agent -- Reservoir -- Vector -- Vehicle -- Incubation Period -- Diagnostic Tests -- Typical Adult Therapy -- Typical Pediatric Therapy -- Clinical Hints -- Synonyms -- References -- Clinical -- References -- Distribution Map -- Images -- The World -- References -- Argentina -- References -- Aruba -- References -- Australia -- References -- Barbados -- References -- Belize -- References -- Brazil -- References -- Cambodia -- References Canada -- References -- Chile -- References -- China -- References -- Colombia -- References -- Cuba -- References -- Ecuador -- References -- Ethiopia -- References -- France -- References -- Germany -- References -- Ghana -- References -- India -- References -- Indonesia -- References -- Iran -- References -- Iraq -- References -- Israel -- References -- Italy -- References -- Japan -- References -- Kenya -- References -- Laos -- References -- Malaysia -- References -- Martinique -- References -- Mexico -- References -- Morocco -- References -- The Netherlands -- References The Netherlands Antilles -- References -- New Zealand -- References -- Nigeria -- References -- Norway -- References -- Oman -- The Philippines -- References -- Poland -- References -- South Korea -- References -- Serbia and Montenegro -- References -- Slovenia -- References -- South Africa -- References -- Spain -- References -- Sri Lanka -- References -- Suriname -- References -- Turkey -- References -- The United Kingdom -- References -- The United States -- References -- Uruguay -- References -- Vietnam -- References -- About GIDEON.
Altri titoli varianti Cutaneous Larva Migrans
Record Nr. UNINA-9910794700803321
Gideon Informatics Inc  
Los Angeles : , : Gideon Informatics, Incorporated, , 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cutaneous Larva Migrans
Cutaneous Larva Migrans
Autore Gideon Informatics Inc
Pubbl/distr/stampa Los Angeles : , : Gideon Informatics, Incorporated, , 2021
Descrizione fisica 1 online resource (27 pages)
Disciplina 616.5
Altri autori (Persone) BergerStephen
Soggetto topico Skin - Infections
ISBN 1-4988-3247-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto CUTANEOUS LARVA MIGRANS: GLOBAL STATUS -- Copyright -- Introduction: The GIDEON e-book series -- Table of Contents -- Cutaneous larva migrans -- Epidemiology -- Agent -- Reservoir -- Vector -- Vehicle -- Incubation Period -- Diagnostic Tests -- Typical Adult Therapy -- Typical Pediatric Therapy -- Clinical Hints -- Synonyms -- References -- Clinical -- References -- Distribution Map -- Images -- The World -- References -- Argentina -- References -- Aruba -- References -- Australia -- References -- Barbados -- References -- Belize -- References -- Brazil -- References -- Cambodia -- References Canada -- References -- Chile -- References -- China -- References -- Colombia -- References -- Cuba -- References -- Ecuador -- References -- Ethiopia -- References -- France -- References -- Germany -- References -- Ghana -- References -- India -- References -- Indonesia -- References -- Iran -- References -- Iraq -- References -- Israel -- References -- Italy -- References -- Japan -- References -- Kenya -- References -- Laos -- References -- Malaysia -- References -- Martinique -- References -- Mexico -- References -- Morocco -- References -- The Netherlands -- References The Netherlands Antilles -- References -- New Zealand -- References -- Nigeria -- References -- Norway -- References -- Oman -- The Philippines -- References -- Poland -- References -- South Korea -- References -- Serbia and Montenegro -- References -- Slovenia -- References -- South Africa -- References -- Spain -- References -- Sri Lanka -- References -- Suriname -- References -- Turkey -- References -- The United Kingdom -- References -- The United States -- References -- Uruguay -- References -- Vietnam -- References -- About GIDEON.
Altri titoli varianti Cutaneous Larva Migrans
Record Nr. UNINA-9910820950003321
Gideon Informatics Inc  
Los Angeles : , : Gideon Informatics, Incorporated, , 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Dermatophytosis
Dermatophytosis
Autore Gideon Informatics Inc
Pubbl/distr/stampa Los Angeles : , : Gideon Informatics, Incorporated, , 2021
Descrizione fisica 1 online resource (38 pages)
Disciplina 616.57
Altri autori (Persone) BergerStephen
Soggetto topico Dermatomycoses
Public health
Epidemiology
ISBN 1-4988-3252-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto DERMATOPHYTOSIS: GLOBAL STATUS -- Copyright -- Introduction: The GIDEON e-book series -- Table of Contents -- Dermatophytosis -- Epidemiology -- Agent -- Reservoir -- Vector -- Vehicle -- Incubation Period -- Diagnostic Tests -- Typical Adult Therapy -- Typical Pediatric Therapy -- Clinical Hints -- Synonyms -- References -- Clinical -- References -- Distribution Map -- Images -- The World -- References -- Albania -- Argentina -- References -- Armenia -- References -- Australia -- References -- Belgium -- References -- Bosnia and Herzegovina -- References -- Brazil -- References -- Cameroon Jamaica -- Japan -- References -- Jordan -- Kazakhstan -- References -- Kenya -- References -- Kuwait -- References -- Libya -- References -- Madagascar -- References -- Malawi -- References -- Mali -- References -- Malta -- References -- Mexico -- References -- Mozambique -- References -- Namibia -- References -- Nepal -- References -- The Netherlands -- References -- New Zealand -- References -- Nigeria -- References -- North Macedonia -- References -- Norway -- References -- Papua New Guinea -- References -- The Philippines -- References -- Poland -- Portugal -- References The Russian Federation -- References -- Saudi Arabia -- References -- Senegal -- References -- Serbia and Montenegro -- References -- Slovakia -- References -- Slovenia -- References -- The Solomon Islands -- References -- South Africa -- References -- Spain -- References -- Sri Lanka -- References -- Sweden -- References -- Switzerland -- References -- Thailand -- References -- Turkey -- References -- Uganda -- References -- The United Kingdom -- References -- The United States -- References -- Vietnam -- References -- Yemen -- References -- About GIDEON.
Altri titoli varianti Dermatophytosis
Record Nr. UNINA-9910794699703321
Gideon Informatics Inc  
Los Angeles : , : Gideon Informatics, Incorporated, , 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Dermatophytosis
Dermatophytosis
Autore Gideon Informatics Inc
Pubbl/distr/stampa Los Angeles : , : Gideon Informatics, Incorporated, , 2021
Descrizione fisica 1 online resource (38 pages)
Disciplina 616.57
Altri autori (Persone) BergerStephen
Soggetto topico Dermatomycoses
Public health
Epidemiology
ISBN 1-4988-3252-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto DERMATOPHYTOSIS: GLOBAL STATUS -- Copyright -- Introduction: The GIDEON e-book series -- Table of Contents -- Dermatophytosis -- Epidemiology -- Agent -- Reservoir -- Vector -- Vehicle -- Incubation Period -- Diagnostic Tests -- Typical Adult Therapy -- Typical Pediatric Therapy -- Clinical Hints -- Synonyms -- References -- Clinical -- References -- Distribution Map -- Images -- The World -- References -- Albania -- Argentina -- References -- Armenia -- References -- Australia -- References -- Belgium -- References -- Bosnia and Herzegovina -- References -- Brazil -- References -- Cameroon Jamaica -- Japan -- References -- Jordan -- Kazakhstan -- References -- Kenya -- References -- Kuwait -- References -- Libya -- References -- Madagascar -- References -- Malawi -- References -- Mali -- References -- Malta -- References -- Mexico -- References -- Mozambique -- References -- Namibia -- References -- Nepal -- References -- The Netherlands -- References -- New Zealand -- References -- Nigeria -- References -- North Macedonia -- References -- Norway -- References -- Papua New Guinea -- References -- The Philippines -- References -- Poland -- Portugal -- References The Russian Federation -- References -- Saudi Arabia -- References -- Senegal -- References -- Serbia and Montenegro -- References -- Slovakia -- References -- Slovenia -- References -- The Solomon Islands -- References -- South Africa -- References -- Spain -- References -- Sri Lanka -- References -- Sweden -- References -- Switzerland -- References -- Thailand -- References -- Turkey -- References -- Uganda -- References -- The United Kingdom -- References -- The United States -- References -- Vietnam -- References -- Yemen -- References -- About GIDEON.
Altri titoli varianti Dermatophytosis
Record Nr. UNINA-9910814476803321
Gideon Informatics Inc  
Los Angeles : , : Gideon Informatics, Incorporated, , 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Dicrocoeliasis
Dicrocoeliasis
Autore Gideon Informatics Inc
Pubbl/distr/stampa Los Angeles : , : Gideon Informatics, Incorporated, , 2021
Descrizione fisica 1 online resource (20 pages)
Disciplina 616.962
Altri autori (Persone) BergerStephen
Soggetto topico Helminthiasis
Dicrocoeliasis
Parasitic diseases
ISBN 1-4988-3253-9
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto DICROCOELIASIS: GLOBAL STATUS; Copyright; Introduction: The GIDEON e-book series; Table of Contents; Dicrocoeliasis; Epidemiology; Agent; Reservoir; Vector; Vehicle; Incubation Period; Diagnostic Tests; Typical Adult Therapy; Typical Pediatric Therapy; Clinical Hints; Synonyms; References; Clinical; References; Distribution Map; Images; The World; References; Afghanistan; References; Canada; References; China; References; The Democratic Republic of Congo; References; Egypt; References; Ghana; References; Greece; References; Haiti; References; India; References; Iran; References; Italy.
Altri titoli varianti Dicrocoeliasis
Record Nr. UNINA-9910794698903321
Gideon Informatics Inc  
Los Angeles : , : Gideon Informatics, Incorporated, , 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Dicrocoeliasis
Dicrocoeliasis
Autore Gideon Informatics Inc
Pubbl/distr/stampa Los Angeles : , : Gideon Informatics, Incorporated, , 2021
Descrizione fisica 1 online resource (20 pages)
Disciplina 616.962
Altri autori (Persone) BergerStephen
Soggetto topico Helminthiasis
Dicrocoeliasis
Parasitic diseases
ISBN 1-4988-3253-9
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto DICROCOELIASIS: GLOBAL STATUS; Copyright; Introduction: The GIDEON e-book series; Table of Contents; Dicrocoeliasis; Epidemiology; Agent; Reservoir; Vector; Vehicle; Incubation Period; Diagnostic Tests; Typical Adult Therapy; Typical Pediatric Therapy; Clinical Hints; Synonyms; References; Clinical; References; Distribution Map; Images; The World; References; Afghanistan; References; Canada; References; China; References; The Democratic Republic of Congo; References; Egypt; References; Ghana; References; Greece; References; Haiti; References; India; References; Iran; References; Italy.
Altri titoli varianti Dicrocoeliasis
Record Nr. UNINA-9910814105903321
Gideon Informatics Inc  
Los Angeles : , : Gideon Informatics, Incorporated, , 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui